Gerald L. Ray & Associates’s Acceleron Pharma Inc. XLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
$321K Sell
8,600
-1,000
-10% -$37.3K 0.04% 270
2017
Q2
$292K Buy
+9,600
New +$292K 0.04% 273